Koyama, H <br/><br/>
The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2.  [electronic resource] 

 -  Circulation research  Oct 1996 
 - 757-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0009-7330 
<br/><br/><label>Standard No.: </label>10.1161/01.res.79.4.757  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--pharmacology<br/>Becaplermin<br/>CDC2-CDC28 Kinases<br/>Cattle<br/>Cells, Cultured<br/>Cyclin-Dependent Kinase 2<br/>Cyclin-Dependent Kinases--metabolism<br/>Cyclohexanes<br/>DNA Replication--drug effects<br/>Drug Antagonism<br/>Insulin-Like Growth Factor I--pharmacology<br/>Muscle, Smooth, Vascular--metabolism<br/>O-(Chloroacetylcarbamoyl)fumagillol<br/>Platelet-Derived Growth Factor--pharmacology<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins c-sis<br/>Sesquiterpenes--pharmacology<br/>Signal Transduction--drug effects